CannaPharmaRX, Inc.
CPMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $820 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $3,755 | $66 | $295 | $14 |
| Gross Profit | -$2,935 | -$66 | -$295 | -$14 |
| % Margin | -357.9% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $593 | $1,250 | $4,906 | $2,614 |
| SG&A Expenses | $598 | $1,347 | $4,906 | $2,614 |
| Sales & Mktg Exp. | $4 | $97 | $0 | $0 |
| Other Operating Expenses | $74 | $234 | $402 | $3 |
| Operating Expenses | $671 | $1,579 | $5,212 | $2,616 |
| Operating Income | -$3,606 | -$1,581 | -$5,212 | -$2,993 |
| % Margin | -439.7% | – | – | – |
| Other Income/Exp. Net | -$6,300 | $5,270 | -$3,319 | -$5,839 |
| Pre-Tax Income | -$9,906 | $3,688 | -$8,531 | -$8,832 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,906 | $3,688 | -$8,531 | -$8,832 |
| % Margin | -1,207.8% | – | – | – |
| EPS | -0.016 | 0.012 | -0.04 | -0.12 |
| % Growth | -232.8% | 129.5% | 66.3% | – |
| EPS Diluted | -0.016 | 0.012 | -0.04 | -0.12 |
| Weighted Avg Shares Out | 625,276 | 308,938 | 211,044 | 74,687 |
| Weighted Avg Shares Out Dil | 625,276 | 308,938 | 211,044 | 74,687 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2 | $2 |
| Interest Expense | $2,264 | $1,697 | $2,290 | $1,507 |
| Depreciation & Amortization | $1 | $128 | $295 | $3 |
| EBITDA | -$7,641 | -$1,447 | -$4,914 | -$2,614 |
| % Margin | -931.7% | – | – | – |